Lower-dose opioids
are not associated with increased hospital admissions or deaths in patients with
very severe chronic obstructive pulmonary disease (COPD) and might be safe for
symptom reduction in severe respiratory disease. However, benzodiazepines and opioids
in higher doses might increase mortality, according to a recent study. The authors state this
study further supports
the safety of regular low-dose systemic opioids to reduce breathlessness in
severely ill patients with respiratory compromise and for those
patients who have an immense need for relief of symptoms.
Safety of benzodiazepines and opioids in very severerespiratory disease: national prospective study.
British
Medical Journal | Jan 30, 2014 (FREE
FULL TEXT)
No comments:
Post a Comment